L-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells

Journal of Neuroscience Research

Volumn 53, Issue 2, 1998, Pages 235-238

  Li, Xin Min ^a   Juorio, Auguste V ^a   Qi, Jin ^a   Boulton, Alan A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cu Zn superoxide dismutase; Neuroprotection; NGF; SOD

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; SELEGILINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; MONOAMINE OXIDASE INHIBITORS; NERVE GROWTH FACTORS; PC12 CELLS; RATS; RNA, MESSENGER; SELEGILINE; SUPEROXIDE DISMUTASE;

EID: 0032527599     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980715)53:2<235::AID-JNR12>3.0.CO;2-5     Document Type: Article

References (48)

1. Ansari K., Yu, PH, Kruck, TP, Tatton, WG (1993): Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: Stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13:4042-4053.
2. Beal MF (1995): Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
3. Birkmayer W, Riederer P, Ambrozi L, Youdim MB (1977): Implications of combined treatment with 'Madopar' and 1-deprenyl in Parkinson's disease, a long term study. Lancet 1:439-443.
4. Bothwell M (1995): Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223-253.
5. Bruyn GW (1968): Huntington's chorea. Historical, clinical and laboratory synopsis. In Vinken PJ, Bruyn GW (eds): "Handbook of Clinical Neurology, Diseases of Basal Ganglia, 6." Amsterdam: North Holland Inc., pp 298-377.
6. Carrillo M C, Kanai S, Nokubo M, Kitani K (1991): (-)Deprenyl induces activities of both Superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48:517-521.
7. Carrillo M C, Kanai S, Nokubo M, Ivy GO, Sato Y, Kitani K (1992): (-)Deprenyl increases activities of Superoxide dismutase and catalase in striatum but not in hippocampus-the sex and age related differences in the optimal dose in the rat. Exp Neurol 48:517-522.
8. Cohen G (1988): Oxygen radicals and Parkinson's disease. Neurology 38:130-135.
9. Coyle JT, Schwanz, R (1976): Lesion of'striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263:244-246.
10. Davies P, Maloney AJF (1976): Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
11. Fainberg A P, Vogelstein B (1983): A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
12. Glover V, Sandier M, Owen F (1977): Dopamine is a monoamine oxidase B substrate in man. Nature 265:80-81.
13. Greene LA (1978): Nerve growth factor prevents the death and stimulates neuronal differentiation of clonal PC 12 pheochromocytoma cells in serum free medium. J Cell Biol 78: 747-755.
14. Greene LA (1982): PC 12 pheochromocytoma cultures in neurobiological research. Adv Cell Neurobiol 3:373-414.
15. Greenlund LJS, Deckwerth TL, Johnson EM (1995): Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 14:303-315.
16. Hornykiewicz O (1972): Dopamine in the basal ganglia. Its role and therapeutic implications. Brit Med Bull 29:172-178.
17. Juorio AV (1988): Brain β-phenylethylamine: localization, pathways, and interaction with catecholamines. In Sandler M, Dahlström A, Belmaker RH (eds): "Progress in Catecholamine Research Part B: Central Aspects." New York: Alan R. Liss, Inc., pp 433-437.
18. Kitani K, Kanai S. Sato Y, Ohta M, Ivy GO, Carrillo M-C (1992) Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats: Further evidence. Life Sci 52: 281-288.
19. Knoll J (1978): The possible mechanisms of action of (-)deprenyl in Parkinson's disease. J Neural Transm 43:117-198.
20. Knoll J (1988): The striatal dopamine dependency of life span in male rats. Longevity study with (-)-deprenyl. Mech Aging Dev 46:237-262.
21. Knoll J, Dallo J, Yen TT (1989): Striatal dopamine, sexual activity and lifespan, longevity of rats treated with (-)deprenyl. Life Sci 45:525-531.
22. Lai CT, Zuo DM, Yu PH (1994): Is brain Superoxide dismutase activity increased following chronic treatment with 1-deprenyl? J Neural Transm 41 :Suppl, 221-229.
23. Levi-Montalcini R (1987): The nerve growth factor 35 years later. Science 237:1154-1162.
24. Li X-M, Juorio A V, Paterson I A, Zhu MY, Boulton AA (1992): Specific irreversible MAO B inhibitors stimulate gene expression of aromatic 1-amino acid decarboxylase in PC12 cells. J Neurochem 59:2324-2327.
25. Li X-M, Qi J, Juorio AV Boulton AA (1993): Reduction in GFAP mRNA abundance induced by (-)-Deprenyl and other MAO B inhibitors in C6 glioma cells. J Neurochem 61:1573-1576.
26. Li X-M., Juorio AV, Boulton AA (1995): Some new mechanisms underlying the actions of (-)-deprenyl: Possible relevance to neurodegeneration. Prog Brain Res 106:99-112.
27. Li X-M, Konradi C, Qi J, Juorio AV, Boulton AA.(1996): (-)-Deprenyl down-regulates low affinity NGF receptor (LNGFR) mRNA in PC 12 cells. J Neurochem 66: (Suppl 2), S11A.
28. Matsui Y, Kumagae K (1991): Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia. Neurosci Lett 126:175-178.
29. Milgram NW, Racine RJ, Nellis P, Mendonca A, Ivy GO (1990): Maintenance on 1-deprenyl prolongs life in aged male rats. Life Sci 47: 415-420.
30. Oppenheim RW (1991): Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501.
31. Parkinson Study Group (1993): Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328:176-183.
32. Paterson IA. Juorio AV Boulton AA (1990): 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem 55:1827-1837.
33. Ricci A, Mancini M, Strocchi P, Bongrani S, Bronzetti E. (1992): Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: Sensitivity to treatment with the monoamine oxidase-B inhibitor 1-deprenyl. Drugs Exp Clin Res 18:163-171.
34. Rodríguez-Gomez JA, Venero JL, Vizuete ML, Cano J, Machado A (1997): Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Mol Brain Res 46:31-38.
35. Rothstein JD, Bristol LA, Hosier B, Brown RH, Kuncl RW (1994): Chronic inhibition of Superoxide dismutase produces apoptotic death in spinal neurons. Proc Natl Acad Sci USA 91:4155-4159.
36. Salo PT, Tatton WG (1992). Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res 31:394-400.
37. Schwartzman RA, Cidlowski JA (1993): Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrine Rev 14:133-151.
38. Spina MB, Cohen G (1989): Dopamine turnover and glutathione oxidation: Implications for Parkinson's disease. Proc Natl Acad Sci USA 86:1398-1400.
39. Stefanis L, Burke RE, Greene LA (1997): Apoptosis in neurodegenerative disorders. Curr. Op Neurol 19:299-305.
40. Tatton WG, Greenwood CE (1991): Rescue of dying neurons, a new action for deprenyl in MPTP parkinsonism. J Neurosci Res 30:666-672.
41. Tatton WG, Ju WYL, Holland DP, Tai C, Kwan M (1994): (-)-Deprenyl reduces PC 12 cell apoptosis by inducing new protein synthesis. J Neurochem 63:1572-1575.
42. Tatton WG, Chalmers-Redman RME, Ju WYH, Wadia J, Tatton NA (1997): Apoptosis in neurodegenerative disorders: Potential therapy by modifying gene transcription. J Neural Transm 49: Suppl, 245-268.
43. Thiffault C, Quirion R, Poirier, J (1997): The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: A possible mechanism leading to an adaptive increase in superoxide dismutase activity. Mol Brain Res 49:127-136.
44. Thoenen H, Barde YA (1980): Physiology of the nerve growth factor. Physiol Rev 60:1284-1335.
45. Troy CM, Shelanski ML (1994): Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC 12 neuronal cells. Proc Natl Acad Sci USA 91:6384-6387.
46. Wilcox BJ, Applegate MD, Portera-Cailliau C, Koliatsos VE (1995): Nerve growth prevents apoptotic cell death in injured central cholinergic neurons. J Comp Neurol 359:573-585.
47. Wyllie AH (1994): Death from inside out: An overview. Phil Trans Roy Soc B 345:237-241.
48. Wyllie AH, Ker JF, Curric AR (1980): Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.